Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Horia Teodor Cotan"'
Autor:
Cristina-Florina Pîrlog, Raluca Costache, Andreea Ioana Paroșanu, Cristina Orlov Slavu, Mihaela Olaru, Ana Maria Popa, Cristian Iaciu, Irina Niță, Pompilia Moțatu, Horia Teodor Cotan, Alexandru Vlad Oprița, Daniel Costache, Loredana Sabina Cornelia Manolescu, Cornelia Nițipir
Publikováno v:
Diagnostics, Vol 13, Iss 11, p 1892 (2023)
Background: Lung cancer (LC) is the first and most lethal cancer in the world; identifying new methods to treat it, such as immune checkpoint inhibitors (ICIs), is needed. ICIs treatment is very effective, but it comes bundled with a series of immune
Externí odkaz:
https://doaj.org/article/71eedd2c07834566a6a2ac720251c1ae
Autor:
Andreea Ioana Parosanu, Cristina Florina Pirlog, Cristina Orlov Slavu, Ioana Miruna Stanciu, Horia-Teodor Cotan, Radu Constantin Vrabie, Ana-Maria Popa, Mihaela Olaru, Cristian Iaciu, Lucian Ioan Bratu, Ionut Florian Baicoianu, Oana Moldoveanu, Catalin Baston, Cornelia Nițipir
Publikováno v:
Current Oncology. 30:2457-2464
Background: Metastatic renal cell carcinoma (mRCC) is an aggressive cancer characterised by an increased recurrence rate and an inadequate response to treatment. This study aimed to investigate the importance of the neutrophil-to-lymphocyte ratio (NL
Autor:
Cristina-Florina Pirlog, Horia Teodor Cotan, Andreea Parosanu, Cristina Orlov Slavu, Ana Maria Popa, Cristian Iaciu, Mihaela Olaru, Alexandru Vlad Oprita, Irina Nita, Cornelia Nitipir
Publikováno v:
Cureus. 14(7)
Background The neutrophil-to-lymphocyte ratio (NLR) at baseline treatment is an important marker of systemic inflammation, which is correlated with survival benefits in lung, breast, ovarian, bladder, and colorectal cancer. Programmed death-ligand 1
Autor:
Alexandra Lazar, Ana Maria Popa, Cristina Orlov-Slavu, Horia-Teodor Cotan, Cristian Ion Iaciu, Cristina Mihaela Olaru, Oliver Daniel Schreiner, Romeo Cristian Ciobanu, Cornelia Nitipir
Publikováno v:
Medicina, Vol 60, Iss 8, p 1290 (2024)
Background and Objectives: Ovarian cancer, including tubal and peritoneal cancer, is the third most common gynecological cancer and the leading cause of death from gynecological malignancies in developed countries. This study explores the prognostic
Externí odkaz:
https://doaj.org/article/563735baa057450c8430ec718d0b8915